gastric cancer tissues; adjacent benign tissue; xenograft tumor tissues; lung tissues
HGC27; MGC803; MKN45; MKN28; SGC7901; AGS; GES-1; HEK-293T
cell line-derived xenograft
PI3K/AKT (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); cell cycle (promotes); ceRNA regulation (promotes); other pathway/process (promotes)
Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; Actinomycin D / DRB Stability Assay; RT-qPCR; RNA-seq; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RNA Pull-Down; ChIP / ChIP-seq; Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Cohort Study; Survival Analysis; Bioinformatics Analysis
High circTDRD3 expression is positively correlated with tumor size and lymph node metastasis, indicates poor prognosis, and may serve as a biomarker for early diagnosis and prognostic assessment.
circTDRD3 (hsa_circ_0003441), derived from TDRD3, is up-regulated in gastric cancer tissues and cell lines and is associated with tumor size, lymph node metastasis, and poor prognosis. It promotes gastric cancer proliferation, migration, invasion, tumor growth, and lung metastasis by sponging miR-891b to increase ITGA2 expression and activate AKT signaling, while ATF4 further promotes TDRD3/circTDRD3 transcription in a positive feedback loop.
0.8981
ATF4-mediated circTDRD3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-891b/ITGA2 axis and AKT signaling pathway.
combined biological and clinical study